Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 415.70
+2.05 (0.50%)
At close: Jun 19, 2026
Biocon Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Biocon stock has a consensus rating of "Buy" and an average price target of ₹414.05. The average 1-year stock price forecast is 0.40% lower than the current stock price, while the lowest is ₹290.00 (-30.24%) and the highest is ₹506.00 (+21.72%).
Price Target: ₹414.05 (-0.40%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biocon stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 9 | 9 | 8 | 8 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 3 | 3 |
| Sell | 3 | 4 | 4 | 4 | 5 | 5 |
| Strong Sell | 2 | 0 | 1 | 1 | 1 | 1 |
| Total | 20 | 19 | 19 | 19 | 20 | 20 |
Financial Forecast
Revenue This Year
199.97B
from 169.27B
Increased by 18.14%
Revenue Next Year
228.53B
from 199.97B
Increased by 14.28%
EPS This Year
8.10
from 5.25
Increased by 54.42%
EPS Next Year
11.77
from 8.10
Increased by 45.34%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 210.6B | ||
| Avg | 200.0B | ||
| Low | 191.4B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 24.4% | ||
| Avg | 18.1% | ||
| Low | 13.1% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 11.30 | ||
| Avg | 8.10 | ||
| Low | 3.59 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 115.4% | ||
| Avg | 54.4% | ||
| Low | -31.6% |